Screening of high-risk groups for breast and ovarian cancer in Europe: A focus on the Jewish population

Oncology Reviews

Volumn 4, Issue 4, 2010, Pages 233-267

  Belkić, Karen L ^a,b,c   Cohen, Miri ^d   Márquez, Marcela ^a,e   Mints, Miriam ^a   Wilczek, Brigitte ^f   Berman, Anne H ^a   Castellanos, Enrique ^a   Castellanos, Martha ^g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CLAREMONT GRADUATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF HAIFA   (Israel)

^e UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^f ST GÖRAN S HOSPITAL   (Sweden)

^g Stockholm Ambulatory Care Center   (Sweden)

Author keywords

BRCA mutations; Breast cancer; Cultural sensitivity; Early detection; Imaging surveillance; Ovarian cancer

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; EARLY DIAGNOSIS; ETHNIC GROUP; EUROPE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENETIC SCREENING; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMMIGRANT; ISRAEL; JEW; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PATIENT COUNSELING; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; UNITED STATES;

EID: 78649666046     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-010-0056-x     Document Type: Review

References (166)

1. DM Parkin F Bray P Pisani 2005 Global cancer statistics CA Cancer J Clin 55 74 108 15761078
2. N Perry C Broeders S Törnberg R Holland L von Karsa 2008 European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-summary document Ann Oncol 19 614 622 18024988
3. P Boyle ME Leon P Maisonneuve P Autier 2003 Cancer control in women: update 2003 Int J Gyneacol Obstet 83 Suppl 1 179 202
4. MA Brewer K Johnson M Follen D Gershenson R Bast 2003 Prevention of ovarian cancer: intraepithelial neoplasia Clin Cancer Res 9 20 30 12538447
5. RJ Kurman K Visvanathan R Roden TC Wu IeM Shih 2008 Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis Am J Obstet Gynecol 198 351 356 18395030
6. ER Woodward HV Sleightholme AM Considine S Williamson JM McHugo DG Cruger 2007 Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective BJOG 114 1500 1509 17903229
7. DŽ Belkić K Belkić 2008 Mathematical modeling applied to an NMR problem in ovarian cancer detection J Math Chem 43 395 425
8. K Bosse K Rhiem B Wappenschmidt M Hellmich M Madeja M Ortmann, et al. 2006 Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study Gynecol Oncol 103 1077 1082 16904167
9. H Kobayashi Y Yamada T Sado M Sakata S Yoshida R Kawaguchi, et al. 2008 A randomized study of screening for ovarian cancer: a multicenter study in Japan Int J Gynecol Cancer 18 414 420 17645503
10. V Nossov M Amneus F Su J Lang JM Janco ST Reddy, et al. 2008 The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol 199 215 223 18468571
11. K Armstrong E Moye S Williams JA Berlin EE Reynolds 2007 Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians Ann Intern Med 146 516 526 17404354
12. D Saslow C Boetes W Burke S Harms MO Leach CD Lehman, et al. 2007 American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 75 89 17392385 (Pubitemid 46535708)
13. T Morimoto T Nagao K Okazaki M Kira Y Nakagawa A Tangoku 2009 Current status of breast cancer screening in the world Breast Cancer 16 2 9 18841333
14. L Tabár B Vitak MF Yen HH Chen RA Smith SW Duffy 2004 Number needed to screen: lives saved over 20 years of follow-up in mammographic screening J Med Screen 11 126 129 15333270
15. M Sant C Allemani R Capocaccia T Hakulinen T Aareleid JW Coebergh, et al. 2003 Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe Int J Cancer 106 416 422 12845683
16. T Sarkeala A Anttila I Saarenmaa M Hakama 2005 Validity of process indicators of screening for breast cancer to predict mortality reduction J Med Screen 12 33 37 15814017
17. DJ MacDonald L Sarna GC Uman M Grant JN Weitzel 2006 Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers Oncol Nurs Forum 33 E27 E35 16518435
18. SA Sabatino RB Burns RB Davis RS Phillips YH Chen EP McCarthy 2004 Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey Cancer 100 2338 2346 15160336
19. M Cohen 2006 Breast cancer early detection, health beliefs and cancer worries in randomly selected women with and without a family history of breast cancer Psychooncology 15 878 883
20. C Isaacs BN Peshkin M Schwartz TA Demarco D Main C Lerman 2002 Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer Breast Cancer Res Treat 71 103 112 11881908
21. B Meiser P Butow A Barratt M Friedlander J Kirk C Gaff, et al. 2000 Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer Breast Cancer Res Treat 59 101 111 10817345 (Pubitemid 30216133)
22. YC Antill J Reynolds MA Young JA Kirk KM Tucker TL Bogtstra, et al. 2006 Screening behavior in women at increased familial risk for breast cancer Fam Cancer 5 359 368 16817030
23. Evans JP, Skrzynia C, Susswein L, Harlan M (2005-2006) Genetics and the young woman with breast cancer. Breast Dis 23:17-29
24. JN Weitzel VI Lagos CA Cullinane PJ Gambol JO Culver KR Blazer, et al. 2007 Limited family structure and BRCA gene mutation status in single cases of breast cancer JAMA 297 2587 2595 17579227
25. AW Kurian AR Hartman MA Mills JM Ford BL Daniel SK Plevritis 2005 Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage Health Expect 8 221 233 16098152
26. A Clements BJ Henderson S Tyndel G Evans K Brian J Austoker, et al. 2007 Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study Eur J Cancer Care 17 245 252
27. MJ Bermejo-Perez S Marquez-Calderon A Llanos-Mendez 2008 Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review Br J Radiol 81 172 179 18208856
28. R Calderon-Margalit O Paltiel 2004 Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature Int J Cancer 112 357 364 15382059
29. SC Willey C Cocilovo 2007 Screening and follow-up of the patient at high risk for breast cancer Obstet Gynecol 110 1404 1416 18055740
30. E Anderson J Berg R Black N Bradshaw J Campbell R Cetnarskyj, et al. 2008 Predicting breast cancer risk: implications of a "weak" family history Fam Cancer 7 361 366 18560993
31. H Eerola C Blomqvist E Pukkala S Pyrhonen H Nevanlinna 2000 Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36 1143 1148 10854948
32. P Møller AI Hagen J Apold L Maehle N Clark B Fiane, et al. 2007 Genetic epidemiology of BRCA mutations-family history detects less than 50% of the mutation carriers Eur J Cancer 43 1713 1717 17574839
33. M Leu K Czene M Reilla 2007 The impact of truncation and missing family links in population-based registers on familial risk estimates Am J Epidemiol 166 1461 1467 17878173
34. M Cohen F Azaiza 2005 Early breast cancer detection practices, health beliefs and cancer worries in Jewish and Arab women Prev Med 41 852 858 16120457
35. SM Goel CC Wee EP McCarthy RB Davis Q Ngo-Metzger RS Phillips 2003 Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care J Gen Intern Med 18 1028 1035 14687262
36. M Lagerlund AE Maxwell R Bastani E Thurfjell A Ekbom M Lambe 2002 Sociodemographic predictors of non-attendance at invitational mammography screening-a population based register study (Sweden) Cancer Cause Control 13 73 82
37. F Sassi HS Luft E Guadagnoli 2006 Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis Am J Public Health 96 2165 2172 17077392
38. L Terán L Baezconde-Garbanati M Márquez E Castellanos K Belkić 2007 On-time mammography screening with a focus on Latinas with low income: a proposed cultural model Anti-Cancer Res 27 4325 4338
39. O Beiki P Allebeck T Nordqvist T Moradi 2009 Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence Eur J Cancer 45 107 118 18829301
40. K Belkić 2004 Current dilemmas and future perspectives for breast cancer screening with a focus upon optimization of magnetic resonance spectroscopic imaging by advances in signal processing Isr Med Assoc J 6 610 618 15473589
41. JD Fackenthal OI Olopade 2007 Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations Nat Rev Cancer 7 937 948 18034184
42. VM Shkolnikov EM Andreev J Anson F Mesle 2004 The peculiar pattern of mortality of Jews in Moscow, 1993-95 Popul Stud 58 311 329
43. H Hampel K Sweet JA Westman K Offit C Eng 2004 Referral for cancer genetics consultation: a review and compilation of risk assessment criteria J Med Genet 41 81 91 14757853
44. National Comprehensive Cancer Network (2007) Clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian. http://www.nccn.org
45. S Barnoy Y Bar-Tal L Treister 2003 Effect of unrealistic optimism, perceived control over disease, and experience with female cancer on behavioral intentions of Israeli women to undergo screening tests Cancer Nurs 26 363 369 14710797
46. O Baron-Epel N Friedman O Lernau 2008 Validity of self-reported mammography in a multicultural population in Israel Prev Med 46 489 491 18407343
47. O Baron-Epel N Friedman O Lernau 2009 Fatalism and mammography in a multicultural population Oncol Nurs Forum 36 353 361 19596653
48. N Bentur R Gross A Berg 1998 Screening tests for early detecting breast cancer in women in Israel-performance rates and patient characteristics Harefuah 134 425 428 10909567, 504
49. M Cohen 2002 First-degree relatives of breast-cancer patients: cognitive perceptions, coping and adherence to breast self-examination Behav Med 28 15 22 12244641
50. S Eilat-Tsanani M Sorek N Gay O Chaimovitch L Kulton H Tabenkin 2001 Family physicians' initiative to increase compliance with screening mammography-an innovative community project Isr Med Assoc J 3 920 924 11794915
51. S Giveon E Kahan 2000 Patient adherence to family practitioners' recommendations for breast cancer screening: a historical cohort study Fam Pract 17 42 45 10673487
52. L Hagoel L Ore E Neter G Shifroni G Rennert 1999 The gradient in mammography screening behavior: a lifestyle marker Soc Sci Med 48 1281 1290 10220026
53. L Hagoel E Neter S Dishon O Barnett G Rennert 2003 BRCA1/2 mutation carriers: living with susceptibility Community Genet 6 242 248 15331870
54. L Keinan-Boker O Baron-Epel N Garty MS Green 2003 Family history of breast cancer and compliance with mammography in Israel: findings of the National Health Survey 2003-2004 (EUROHIS) Eur J Cancer Prev 16 43 49
55. S Kreitler S Chaitchik H Kreitler 1990 The psychological profile of women attending breast-screening tests Soc Sci Med 31 1177 1185 2274806
56. L Lubish S Greenberg M Friger P Shvartzman 2001 Breast cancer screening in two multicultural family practice teaching clinics Isr Med Assoc J 3 579 583 11519382
57. L Ore L Hagoel G Shifroni G Rennert 1997 Compliance with mammography screening in Israeli women: the impact of a pre-scheduled appointment and of the letter-style Isr J Med Sci 33 103 111 9254871
58. L Remennick 1999 Preventive behavior among recent immigrants: Russian-speaking women and cancer screening in Israel Soc Sci Med 48 1669 1684 10400265
59. L Remennick 1999 Breast screening practices among Russian immigrant women in Israel Women Health 28 29 51 10378344
60. L Remennick 2003 "I have no time for potential troubles": Russian immigrant women and breast cancer screening in Israel J Immigr Health 5 153 163 14574066
61. PE Slater H Aviram M Dagan S Yosselson-Superstine R Cristal I Rubinstein, et al. 1990 Breast cancer screening in Tel Aviv Eur J Epidemiol 6 253 256 2253728
62. M DiCastro M Frydman I Friedman R Shiri-Sverdlov MZ Papa B Goldman, et al. 2002 Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information Am J Med Genet 111 147 151 12210341
63. SM Albert S Harlap L Caplan 2004 Cancer screening among older women in a culturally insular community Prev Med 39 649 656 15351529
64. DJ Bowen R Singal E Eng S Crystal W Burke 2003 Jewish identity and intentions to obtain breast cancer screening Cultur Divers Ethnic Minor Psycho 9 79 87
65. SS Goodwin PF Visintainer J Facelle CE Falvo 2006 Breast cancer screening in Rockland County, New York: a survey of attitudes and behaviors Ethnic Dis 16 428 434
66. SE Plon LE Peterson LC Friedman CS Richards 2000 Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study Genet Med 2 307 311 11339650
67. K Armstrong K Calzone J Stopfer G Fitzgerald J Coyne B Weber 2000 Factors associated with decisions about clinical BRCA1/2 testing Cancer Epidemiol Biomarkers Prev 9 1251 1254 11097234
68. DJ Bowen W Burke JO Culver N Press S Crystal 2006 Effects of counseling Ashkenazi Jewish women about breast cancer risk Cult Divers Ethnic Min Psychol 12 45 56
69. DJ Bowen E Bourcier N Press FM Lewis W Burke 2004 Effects of individual and family functioning on interest in genetic testing Community Genet 7 25 32 15475668
70. J Culver W Burke Y Yasui S Durfy N Press 2001 Participation in breast cancer genetic counseling: the influence of educational level, ethnic background, and risk perception J Genet Counsel 10 215 231
71. S Durfy D Bowen A McTiernan J Spoleder W Burke 1999 Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington Cancer Epidemiol Biomarkers Prev 8 Pt. 2 369 375 10207642
72. LC Friedman JA Webb CS Richards GR Lynch AL Kaplan FC Brunicardi SE Plon 1999 Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim Genet Med 1 74 79 11336456
73. LS Lehmann JC Weeks N Klar JE Garber 2002 A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing Genet Med 4 346 352 12394347
74. LS Lehmann JC Weeks N Klar L Biener JE Garber 2000 Disclosure of familial genetic information: perceptions of the duty to inform Am J Med 109 705 711 11137485
75. NA Press Y Yasui S Reynolds SJ Durfy W Burke 2001 Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations Am J Med Genet 99 99 110 11241466
76. L Andrews B Meiser C Apicella K Tucker 2004 Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study Genet Test 8 240 247 15727246
77. C Apicella SJ Peacock L Andrews K Tucker A Bankier MB Daly, et al. 2006 Determinants of preferences for genetic counseling in Jewish women Fam Cancer 5 159 167 16736286
78. S Peacock C Apicella L Andrews K Tucker A Bankier MB Daly, et al. 2006 A discrete choice experiment of preferences for genetic counseling among Jewish women seeking cancer genetics services Br J Cancer 95 1448 1453 17102813
79. Israel Central Bureau of Statistics (2008) Statistical abstract of Israel: localities, population and density per sq. km., by metropolitan area and selected localities (Number 2.6). Jerusalem, Israel
80. ML Essink-Bot AJ Rijnsburger S van Dooren HJ de Koning C Seynaeve 2006 Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition Breast 15 673 676 16556497
81. M Kriege CT Brekelmans C Boetes EJT Rutgers JC Oosterwijk RAEM Tollenaar, et al. 2001 MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC) Fam Cancer 1 163 168 14574173
82. M Kriege C Brekelmans C Boetes PE Besnard HM Zonderland IM Obdeijn, et al. 2004 Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 427 437 15282350
83. M Kriege CT Brekelmans C Boetes SH Muller HM Zonderland IM Obdeijn, et al. 2006 Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition Cancer 106 2318 2326 16615112
84. M Kriege CT Brekelmans H Peterse IM Obdeijn C Boetes HM Zonderland, et al. 2007 Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer Breast Cancer Res Treat 102 357 363 17051427
85. K Pieterse S van Dooren C Seynaeve CC Bartels AJ Rijnsburger HJ de Koning, et al. 2007 Passive coping and psychological distress in women adhering to regular breast cancer surveillance Psychooncology 16 851 858 17219399
86. MM Tilanus-Linthorst M Kriege C Boetes WC Hop IM Obdeijn JC Oosterwijk, et al. 2005 Hereditary breast cancer growth rates and its impact on screening policy Eur J Cancer 41 1610 1617 15978801
87. MM Tilanus-Linthorst IM Obdeijn KC Bartels HJ de Koning M Oudkerk 2000 First experiences in screening women at high risk for breast cancer with MR imaging Breast Cancer Res Treat 63 53 60 11079159
88. J Brown A Coulthard AK Dixon JM Dixon DF Easton RA Eeles, et al. 2000 Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer Breast 9 78 82 14731703 (Pubitemid 30261253)
89. J Brown A Coulthard AK Dixon JM Dixon DF Easton RA Eeles, et al. 2000 Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer Breast 9 72 77 14731702 (Pubitemid 30261252)
90. J Brown D Buckley A Coulthard AK Dixon JM Dixon DF Easton, et al. 2000 Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group Magn Reson Imaging 18 765 776 11027869
91. I Griebsch J Brown C Boggis A Dixon M Dixon D Easton, et al. 2006 Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer Br J Cancer 95 801 810 17016484
92. GP Gui RK Hogben G Walsh R A'Hern R Eeles 2001 The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography? Eur J Cancer 37 1668 1673 11527694
93. GP Gui G Kadayaprath N Darhouse J Self A Ward R A'Hern, et al. 2006 Clinical outcome and service implications of screening women at increased breast cancer risk from a family history Eur J Surg Oncol 32 719 724 16784834
94. MO Leach the MARIBS Advisory Group, Staff and Collaborating Centres 2002 The UK National study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS) J Exp Clin Cancer Res 21 3 Suppl 107 114 12585664
95. MO Leach CR Boggis AK Dixon DF Easton RA Eeles DG Evans, et al. 2005 Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 1769 1778 15910949
96. MM Tilanus-Linthorst IM Obdeijn KC Bartels 2005 MARIBS study Lancet 366 291 292 16039329
97. RM Warren D Thompson LJ Pointon R Hoff FJ Gilbert AR Padhani, et al. 2006 Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening study Radiology 239 677 685 16714457
98. V Murday R Pears J Ball R Eeles S Hodgson 2004 An audit of screening for familial breast cancer before 50 years in the South Thames Region-have we got it right? Fam Cancer 3 29 34 15131403
99. J Kollias DM Sibbering RW Blamey PA Holland Z Obuszko AR Wilson, et al. 1998 Screening women aged less than 50 years with a family history of breast cancer Eur J Cancer 34 878 883 9797701
100. RK Schmutzler K Rhiem P Breuer E Wardelmann M Lehnert S Coburger, et al. 2006 Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer Eur J Cancer Prevent 15 483 489
101. CK Kuhl 2002 High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) J Exp Clin Cancer Res 21 Suppl 103 106 12585663
102. CK Kuhl S Schrading CC Leutner N Markkabati-Spitz E Wardelmann R Fimmers, et al. 2005 Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer J Clin Oncol 23 8469 8476 16293877
103. CK Kuhl W Kuhn H Schild 2005 Management of women at high risk for breast cancer: new imaging beyond mammography Breast 14 480 486 16185869
104. S Schrading CK Kuhl 2008 Mammographic, US, and MR imaging phenotypes of familial breast cancer Radiology 246 58 70 18096529
105. F Sardanelli F Podo G D'Agnolo A Verdecchia M Santaquilani R Musumeci, et al. 2007 Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results Radiology 242 698 715 17244718
106. L Cortesi D Turchetti I Marchi A Fracca B Canossi B Rachele, et al. 2006 Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience BMC Cancer 6 210 10.1186/1471-2407-6-210 16916448 (Pubitemid 44382758)
107. M Federico A Maiorana L Mangone D Turchetti B Canossi L Cortesi, et al. 1999 Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal Breast Cancer Res Treat 55 213 221 10517166
108. G Trecate D Vergnaghi S Manoukian S Bergonzi G Scaperrotta M Marchesini, et al. 2006 MRI in the early detection of breast cancer in women with high genetic risk Tumori 92 517 523 17260493
109. J Gronwald T Byrski T Huzarski C Cybulski M Stawicka M Szwiec, et al. 2007 A survey of preventive measures among BRCA1 mutation carriers from Poland Clin Genet 71 153 157 17250664
110. B Górski A Jakubowska T Huzarski T Byrski J Gronwald E Grzybowska, et al. 2004 A high proportion of founder BRCA1 mutations in Polish breast cancer families Int J Cancer 110 683 686 15146557
111. E Daguet C Malhaire C Hardit A Athanasiou C El Khoury F Thibault, et al. 2008 MR breast screening in patients with genetic mutation J Radiol 89 783 790 18641565
112. CC Riedl L Ponhold D Flory M Weber R Kroiss T Wagner, et al. 2007 Magnetic resonance imaging of the breast improves detection of invasive cancer, pre-invasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer Clin Cancer Res 13 6144 6152 17947480
113. R Kroiss V Winkler K Kalteis D Bikas M Rudas M Tea, et al. 2008 Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group J Cancer Res Clin Oncol 134 1113 1121 18392852
114. R Kroiss V Winkler D Bikas E Fleischmann C Mainau F Frommlet, et al. 2005 Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers Hum Mutat 26 583 589 16287141
115. A Dørum GB Kristensen VM Abeler CG Trope P Moller 1996 Early detection of familial ovarian cancer Eur J Cancer 32A 1645 1651 8983269
116. A Dørum K Heimdal K Lovslett G Kristensen LJ Hansen R Sandvei, et al. 1999 Prospectively detected cancer in familial breast/ovarian cancer screening Acta Obstet Gynecol Scand 78 906 911 10577622
117. DG Evans KN Gaarenstroom D Stirling A Shenton L Maehle A Dørum, et al. 2009 Screening for familial ovarian cancer: poor survival of BRCA 1/2 cancers J Med Genetics 46 593 597
118. KN Gaarenstroom B van der Hiel RA Tollenaar GR Vink FW Jansen CJ van Asperen, et al. 2006 Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study Int J Gynecol Cancer 16 Suppl 1 54 59 16515568
119. RI Olivier MA Lubsen-Brandsma S Verhoef M van Beurden 2006 CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer Gynecol Oncol 100 20 26 16188302
120. AL Oei LF Massuger J Bulten MJH Ligtenberg NH Hoogerbrugge JAH de Hullu 2006 Surveillance of women at high risk for hereditary ovarian cancer is inefficient Br J Cancer 27 94 814 819
121. IJ Jacobs J Mackay U Menon SJ Skates AN Rosenthal L Fraser 2006 Familial ovarian screening-effective or ineffective? Br J Cancer 95 1124 17047658
122. U Menon SJ Skates S Lewis AN Rosenthal B Rufford K Sibley, et al. 2005 Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer J Clin Oncol 23 7919 7926 16258091
123. GC Rieck K Lim MT Rogers E France JR Gray N Amso, et al. 2006 Screening for familial ovarian cancer-management and outcome of women with moderate to high risk of developing ovarian cancer Int J Gynecol Cancer 16 Suppl 1 86 91 16515573
124. A Tailor T Bourne S Campbell E Okokon T Dew WP Collins 2003 Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study Ultrasound Obstet Gynecol 21 378 385 12704748
125. E Andolf C Jorgensen B Astedt 1990 Ultrasound examination for detection of ovarian carcinoma in risk groups Obstet Gynecol 75 106 109 2404221
126. E Andolf 1993 Ultrasound screening in women at risk for ovarian cancer Clin Obstet Gynecol 36 423 432 8513636
127. B Arver A Borg A Lindblom 2001 First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm Genet Test 5 1 8 11336395
128. B Arver A Haegermark U Platten A Lindblom Y Brandberg 2004 Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up Fam Cancer 3 109 116 15340261
129. M Zelada-Hedman B Wasteson Arver A Claro J Chen B Werelius H Kok, et al. 1997 A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region Cancer Res 57 2474 2477 9192828 (Pubitemid 27255909)
130. MP Lux S Ackermann C Nestle-Krämling TO Goecke D Niederacher R Bodden-Heidrich, et al. 2005 Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer Eur J Cancer Prev 14 399 411 16030432 (Pubitemid 41104950)
131. MP Lux S Ackermann MR Bani C Nestle-Krämling TO Goecke D Niederacher, et al. 2005 Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer Eur J Cancer Prev 14 503 511 16284494 (Pubitemid 41689649)
132. S Hofvind B Geller PM Vacek S Thoresen P Skaane 2007 Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program Eur J Epidemiol 22 447 455 17594526
133. EE Calle WD Flanders MJ Thun LM Martin 1993 Demographic predictors of mammography and Pap smear screening in US women Am J Public Health 83 53 60 8417607
134. B Moy ER Park S Feibelmann S Chiang JS Weissman 2006 Barriers to repeat mammography: Cultural perspectives of African-American, Asian and Hispanic women Psychooncology 15 623 634 16304623
135. M Trigoni F Griffiths D Tsiftsis E Koumantakis E Green C Lionis 2008 Mammography screening: views from women and primary care physicians in Crete BMC Women's Health 8 20 10.1186/1472-6874-8-20 18990253
136. SD Fischera DI Frank 1994 The health belief model as a predictor of mammography screening Health Values 18 3 9
137. D Montano S Taplin 1991 A test of an expanded theory of reasoned action to predict mammography participation Soc Sci Med 32 733 741 2035050
138. R Pasick N Burke 2008 A critical review of theory in breast cancer screening promotion across cultures Annu Rev Public Health 29 351 368 17914932
139. RT Brandt HT Lynch 2001 BRCA1 and BRCA2: to test or not to test Breast Cancer Res Treat 67 187 188 11519868
140. M Prochazka P Hall F Granath K Czene 2006 Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study Br J Cancer 95 1291 1295 17024122
141. SI Brandt-Rauf VH Raveis NF Drummond JA Conte SM Rothman 2006 Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease Am J Public Health 96 1979 1988 17018815
142. A Surbone 2001 Ethical implications of genetic testing for breast cancer susceptibility Crit Rev Oncol Hematol 40 149 157 11682322
143. L Baider T Peretz P Ever-Hadani S Perry R Avramov A Kaplan De-Nour 2000 Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancer Am J Psychiatry 157 904 910 10831469
144. L Baider G Goldzweig P Ever-Hadani T Peretz 2006 Psychological distress and coping in breast cancer patients and healthy women whose patients survived the Holocaust Psychooncology 15 635 646 16363011
145. L Baider G Goldzweig P Ever-Hadani T Peretz 2008 Breast cancer and psychological distress: mothers' and daughters' traumatic experiences Support Care Cancer 16 407 414 17710444
146. L Keinan-Boker N Van-Raviv I Liphshitz S Linn M Barchana 2009 Cancer incidence in Israeli Jewish survivors of World War II J Natl Cancer Inst 101 1489 1500 19861305
147. LA Newman T Hurd M Leitch HM Kuerer K Diehl A Lucci, et al. 2004 A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group J Am Coll Surg 199 644 651 15454152
148. C Guevara C Cook N Herback R Pietrobon DO Jacobs TP Vail 2006 Gender, racial, and ethnic disclosure in NIH K-Award funded diabetes and obesity clinical trials Acc Res 13 311 324
149. DO Erwin VA Johnson M Trevino K Duke L Feliciano L Jandorf 2007 A comparison of African American and Latin social networks as indicators for culturally tailoring a breast and cervical cancer education intervention Cancer 109 Suppl 2 368 377 17173279
150. K Glanz RT Croyle VY Chollette VW Pinn 2003 Cancer-related health disparities in women Am J Public Health 93 292 298 12554589
151. B Meiser M Eisenbruch K Barlow-Stewart K Tucker Z Steel D Goldstein 2001 Cultural aspects of cancer genetics: setting a research agenda J Med Genet 38 425 429 11432959
152. Cohen M, Azaiza F (2010) Increasing breast examination among Arab women using a tailored culture-based intervention. Behav Med (in press)
153. AM Navarro KL Senn LJ McNicholas RM Kaplan B Roppe MC Campo 1998 Por la Vida model intervention enhances use of cancer screening tests among Latinas Am J Prev Med 15 32 41 9651636
154. U.S. Preventive Services Task Force 2004 Screening for ovarian cancer: recommendation statement Ann Fam Med 2 260 262
155. SS Buys E Partridge MH Greene PC Prorok D Reding TL Riley, et al. 2005 Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial Am J Obstet Gynecol 193 1630 1639 16260202 (Pubitemid 41540458)
156. PM McGovern CR Gross RA Krueger DA Engelhard JE Cordes TR Church 2004 False-positive cancer screens and health-related quality of life Cancer Nurs 27 347 352 15525861
157. J Yu A Park E Morris L Liberman PI Borgen TA King 2008 MRI screening in a clinic population with a family history of breast cancer Ann Surg Oncol 15 452 461 18026801
158. M Robson 2004 Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations Clin Breast Cancer 5 260 268 15507170
159. KY Gregory-Mercado J Will S True J Royalty ET Starcher O Khavjou, et al. 2007 A combined approach to women's health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women Public Health Res 4 1 9
160. CC Wee EP McCarthy RB Davis RS Phillips 2000 Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care Ann Intern Med 132 697 704 10787362
161. GE Feldman 2001 Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts Isr Med Assoc J 3 341 346 11411198
162. PC Allgood J Warwick RM Warren NE Day SW Duffy 2008 A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality Br J Cancer 98 206 209 18059396
163. A Anttila J Koskela M Hakama 2002 Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland J Med Screen 9 153 158 12518004
164. R Gabe L Tryggvadottir BF Sigfússon GH Olafsdottir K Sigurdsson SW Duffy 2007 A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death Acta Radiol 48 948 955 18080359
165. Council of the European Union (2008) Council conclusions on reducing the burden of cancer. 2876th Employment, Social Policy, Health and Consumer Affairs Council Meeting, Luxembourg, 10 June 2008
166. A Meindl German Consortium for Hereditary Breast and Ovarian Cancer 2002 Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population Int J Cancer 97 472 480 11802209